Makes neffy, a needle-free nose spray for severe allergic reactions.
No change
Third Point owns 1.0 million shares of ARS Pharma, worth about $8 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
1,000,000
Jun 30
1,000,000
The numbers
Shares they own
1,000,000
Value on Jun 30, 2026
$8,010,000
about $8 million
Share of their money
0.2%
less than $1 of every $100 · 28th of 35
Price per share on Jun 30
$8.01
Kind
Shares
Also owned by
No other fund we follow
More about ARS Pharma ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.